
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6577807
[patent_doc_number] => 20100273865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'Polypeptides involved in neuronal regeneration-associated gene expression'
[patent_app_type] => utility
[patent_app_number] => 12/771417
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25679
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273865.pdf
[firstpage_image] =>[orig_patent_app_number] => 12771417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/771417 | Polypeptides involved in neuronal regeneration-associated gene expression | Apr 29, 2010 | Abandoned |
Array
(
[id] => 10882230
[patent_doc_number] => 08906607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Method for modulating double-strand break-induced homologous recombination'
[patent_app_type] => utility
[patent_app_number] => 13/695225
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 26192
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695225
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/695225 | Method for modulating double-strand break-induced homologous recombination | Apr 29, 2010 | Issued |
Array
(
[id] => 9482512
[patent_doc_number] => 08728458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Combination anti-HIV vectors, targeting vectors, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/266236
[patent_app_country] => US
[patent_app_date] => 2010-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25562
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266236
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266236 | Combination anti-HIV vectors, targeting vectors, and methods of use | Apr 28, 2010 | Issued |
Array
(
[id] => 7784786
[patent_doc_number] => 20120046342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'OLIGONUCLEOTIDE COMPRISING AN INOSINE FOR TREATING DMD'
[patent_app_type] => utility
[patent_app_number] => 13/266110
[patent_app_country] => US
[patent_app_date] => 2010-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24811
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046342.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266110
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266110 | OLIGONUCLEOTIDE COMPRISING AN INOSINE FOR TREATING DMD | Apr 25, 2010 | Abandoned |
Array
(
[id] => 7523199
[patent_doc_number] => 08026355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Oligomeric compounds for the modulation of survivin expression'
[patent_app_type] => utility
[patent_app_number] => 12/765673
[patent_app_country] => US
[patent_app_date] => 2010-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 37149
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026355.pdf
[firstpage_image] =>[orig_patent_app_number] => 12765673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/765673 | Oligomeric compounds for the modulation of survivin expression | Apr 21, 2010 | Issued |
Array
(
[id] => 6646211
[patent_doc_number] => 20100228018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/765818
[patent_app_country] => US
[patent_app_date] => 2010-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 60419
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20100228018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12765818
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/765818 | RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Apr 21, 2010 | Abandoned |
Array
(
[id] => 6402825
[patent_doc_number] => 20100305191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA'
[patent_app_type] => utility
[patent_app_number] => 12/754111
[patent_app_country] => US
[patent_app_date] => 2010-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35154
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12754111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/754111 | RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA | Apr 4, 2010 | Abandoned |
Array
(
[id] => 8128557
[patent_doc_number] => 20120088815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'Modified Oligonucleotide and Its Preparation and Application'
[patent_app_type] => utility
[patent_app_number] => 13/262702
[patent_app_country] => US
[patent_app_date] => 2010-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27188
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088815.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262702
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262702 | Modified oligonucleotide and its preparation and application | Mar 29, 2010 | Issued |
Array
(
[id] => 8375500
[patent_doc_number] => 08258289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Modulation of diacylglycerol acyltransferase 2 expression'
[patent_app_type] => utility
[patent_app_number] => 12/748281
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46191
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12748281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748281 | Modulation of diacylglycerol acyltransferase 2 expression | Mar 25, 2010 | Issued |
Array
(
[id] => 7768166
[patent_doc_number] => 20120035247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 13/255744
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 41605
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035247.pdf
[firstpage_image] =>[orig_patent_app_number] => 13255744
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/255744 | RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA) | Mar 16, 2010 | Abandoned |
Array
(
[id] => 6569641
[patent_doc_number] => 20100234447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'MODULATION OF GLUCAGON RECEPTOR EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/725359
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31606
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12725359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/725359 | MODULATION OF GLUCAGON RECEPTOR EXPRESSION | Mar 15, 2010 | Abandoned |
Array
(
[id] => 6569682
[patent_doc_number] => 20100234450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Molecular targeting agents'
[patent_app_type] => utility
[patent_app_number] => 12/661398
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26394
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234450.pdf
[firstpage_image] =>[orig_patent_app_number] => 12661398
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/661398 | Molecular targeting agents | Mar 15, 2010 | Abandoned |
Array
(
[id] => 8199876
[patent_doc_number] => 20120123096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'THERAPEUTIC NUCLEIC ACID-3\'-CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 12/716088
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13832
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20120123096.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716088
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716088 | Therapeutic nucleic acid-3′-conjugates | Mar 1, 2010 | Issued |
Array
(
[id] => 9046831
[patent_doc_number] => 08541385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/714863
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 35
[patent_no_of_words] => 39964
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714863 | Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof | Feb 28, 2010 | Issued |
Array
(
[id] => 7766099
[patent_doc_number] => 20120034189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'MEANS AND METHODS FOR DURABLE INHIBITION OF PATHOGENS'
[patent_app_type] => utility
[patent_app_number] => 13/203519
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17142
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034189.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203519 | MEANS AND METHODS FOR DURABLE INHIBITION OF PATHOGENS | Feb 25, 2010 | Abandoned |
Array
(
[id] => 6231980
[patent_doc_number] => 20100184825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering Nucleic Acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/712985
[patent_app_country] => US
[patent_app_date] => 2010-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 85977
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184825.pdf
[firstpage_image] =>[orig_patent_app_number] => 12712985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/712985 | RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA) | Feb 24, 2010 | Issued |
Array
(
[id] => 7778671
[patent_doc_number] => 20120041049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'DESIGN OF SMALL-INTERFERING RNA'
[patent_app_type] => utility
[patent_app_number] => 13/148932
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6359
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041049.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148932 | DESIGN OF SMALL-INTERFERING RNA | Feb 23, 2010 | Abandoned |
Array
(
[id] => 6632017
[patent_doc_number] => 20100311814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MODULATION OF STAT5 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/710232
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24476
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710232 | Modulation of stat5 expression | Feb 21, 2010 | Issued |
Array
(
[id] => 6632017
[patent_doc_number] => 20100311814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MODULATION OF STAT5 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/710232
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24476
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710232 | Modulation of stat5 expression | Feb 21, 2010 | Issued |
Array
(
[id] => 6632017
[patent_doc_number] => 20100311814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MODULATION OF STAT5 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/710232
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24476
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710232 | Modulation of stat5 expression | Feb 21, 2010 | Issued |